Difficulty: Medium
Average Score: 63%
Practice
Your patient with rheumatoid arthritis (RA) is taking prednisone (Deltasone) and naproxen (Alleve) to reduce inflammation and joint pain. Which of these symptoms is the strongest indicator that a change in therapy may be necessary?
Correct answer
D
Rationale
In this scenario, the correct answer is D) The patient has stools that are very dark in color. Dark stools indicate gastrointestinal bleeding, a serious side effect of NSAIDs like naproxen. This is a critical symptom that requires immediate attention and may necessitate a change in therapy to prevent further complications.
Option A is incorrect as morning stiffness is a common feature of RA and not necessarily an indicator for changing therapy. Option B about dry eyes is more likely related to Sjogren's syndrome, which can coexist with RA but is not a strong indicator for changing therapy in this case. Option C refers to rheumatoid nodules, a common manifestation of RA but not a direct indicator for changing therapy.
Educationally, it is crucial for healthcare providers to recognize and monitor for adverse effects of medications used in RA treatment, especially NSAIDs like naproxen. Understanding the significance of symptoms like dark stools can help prevent serious complications and optimize patient care. Regular monitoring and patient education on potential side effects are essential in managing RA pharmacotherapy effectively.
Option A is incorrect as morning stiffness is a common feature of RA and not necessarily an indicator for changing therapy. Option B about dry eyes is more likely related to Sjogren's syndrome, which can coexist with RA but is not a strong indicator for changing therapy in this case. Option C refers to rheumatoid nodules, a common manifestation of RA but not a direct indicator for changing therapy.
Educationally, it is crucial for healthcare providers to recognize and monitor for adverse effects of medications used in RA treatment, especially NSAIDs like naproxen. Understanding the significance of symptoms like dark stools can help prevent serious complications and optimize patient care. Regular monitoring and patient education on potential side effects are essential in managing RA pharmacotherapy effectively.